Mitchell H. Finer, Chief Scientific Officer at bluebird bio, Inc. (BLUE), sold 30,000 shares at $117.39 ($3.5M) on 2015-04-01, disclosed to the SEC on 2015-04-03.
Scheduled sale ($3.5M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $116.54 | 10,941 | $1.3M | 36.0% |
| 2 | $117.39 | 4,245 | $498K | 14.1% |
| 3 | $118.59 | 6,231 | $739K | 20.9% |
| 4 | $119.54 | 8,491 | $1.0M | 28.7% |
| 5 | $120.17 | 92 | $11K | 0.3% |
| Total | $117.95 avg | 30,000 |
| $3.5M |
| 100% |
| Filing → |
| BLUE | SELL | 2015-05-19 | $2.3M | — | Filing → |
| BLUE | SELL | 2015-05-06 | $2.0M | — | Filing → |
| BLUE | SELL | 2015-04-22 | $1.9M | — | Filing → |